Publication | Closed Access

Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor

Codon 148Human RetrovirusPathogenesisImmunologyAntiviral Drug DevelopmentResistance Mutation (Virology)VirologyAntiviral TherapyAntiviral DrugHivMedicineAntimicrobial ResistanceDrug Resistance